Article

Geddes J, Freemantle N, Harrison P, Bebbington P. The National Schizophrenia Guideline Development Group. Atypical antipsychotics in the treatment of schizophrenia systematic overview and meta-regression analysis. Br Med J 321: 1371-1376

Department of Psychiatry University of Oxford, Warneford Hospital, Oxford OX3 7JX.
BMJ Clinical Research (Impact Factor: 14.09). 01/2001; 321(7273):1371-6. DOI: 10.1136/bmj.321.7273.1371
Source: PubMed

ABSTRACT To develop an evidence base for recommendations on the use of atypical antipsychotics for patients with schizophrenia.
Systematic overview and meta-regression analyses of randomised controlled trials, as a basis for formal development of guidelines.
12 649 patients in 52 randomised trials comparing atypical antipsychotics (amisulpride, clozapine, olanzapine, quetiapine, risperidone, and sertindole) with conventional antipsychotics (usually haloperidol or chlorpromazine) or alternative atypical antipsychotics.
Overall symptom scores. Rate of drop out (as a proxy for tolerability) and of side effects, notably extrapyramidal side effects.
For both symptom reduction and drop out, there was substantial heterogeneity between the results of trials, including those evaluating the same atypical antipsychotic and comparator drugs. Meta-regression suggested that dose of conventional antipsychotic explained the heterogeneity. When the dose was </=12 mg/day of haloperidol (or equivalent), atypical antipsychotics had no benefits in terms of efficacy or overall tolerability, but they still caused fewer extrapyramidal side effects.
There is no clear evidence that atypical antipsychotics are more effective or are better tolerated than conventional antipsychotics. Conventional antipsychotics should usually be used in the initial treatment of an episode of schizophrenia unless the patient has previously not responded to these drugs or has unacceptable extrapyramidal side effects.

Download full-text

Full-text

Available from: Paul E Bebbington, Sep 05, 2015
0 Followers
 · 
110 Views
 · 
51 Downloads
  • Source
    • "Since the 1950s the number of psychotropic medications available has increased.1 Drug treatments showed utility for psychoses2 and depression,3 although arguably the benefit has been overvalued.4-6 By contrast, there is little evidence of utility for people with personality disorder. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aims and method To explore experiences of psychiatrists considering medication for patients with personality disorder by analysis of transcribed, semi-structured interviews with consultants. Results Themes show important relational processes in which not prescribing is expected to be experienced as uncaring rejection, and psychiatrists felt helpless and inadequate as doctors when unable to relieve symptoms by prescribing. Discontinuity in doctor-patient relationships compounds these problems. Clinical implications Problems arise from: (a) the psychopathology creating powerful relational effects in consultation; (b) the lack of effective treatments, both actual and secondary to under-resourcing and neglect of non-pharmaceutical interventions; and (c) the professionally constructed role of psychiatrists prioritising healing and cure through provision of technological interventions for specific diagnoses. There is a need for more treatments and services for patients with personality disorder; more support and training for psychiatrists in the relational complexities of prescribing; and a rethink of the trend for psychiatrists to be seen primarily as prescribers.
    06/2014; 38(3):116-21. DOI:10.1192/pb.bp.113.044081
  • Source
    • "Typical antipsychotics exemplified by haloperidol form the basis of psychosis treatment [1], and are occasionally used to manage Tourette's syndrome [2], nausea, and vomiting [3]. These agents have high affinity for D 2 dopamine receptors [4]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Typical antipsychotics are characterized by extrapyramidal syndrome (EPS). Previous studies demonstrated that typical antipsychotics could inhibit neuronal voltage-gated sodium channel (VGSC). However, EPS typically emerge only upon prolonged exposure. As a result, we examined effects of haloperidol, a prototype typical antipsychotic, on neuronal VGSC upon incubation for varying duration. Briefly, VGSC currents were activated and recorded using a whole-cell patch-clamp technique in primary culture of mouse cortical neurons. VGSC activity was inhibited by acute haloperidol exposure (for minutes), but enhanced in a time- and concentration-dependent manner by chronic haloperidol exposure (for hours). The effects of chronic haloperidol were associated with increased expression of VGSC subunits as well as corresponding electrophysiological channel properties. In summary, we found enhanced VGSC currents upon chronic haloperidol exposure in cortical neurons in contrast to inhibition by acute haloperidol exposure. Such a results may contribute to EPS of typical antipsychotics.
    Biochemical and Biophysical Research Communications 05/2014; 450(1). DOI:10.1016/j.bbrc.2014.05.081 · 2.28 Impact Factor
  • Source
    • "There is no clear evidence to whether atypical antipsychotics are more effective or are better tolerated than conventional antipsychotics.10 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Schizophrenic patients who receive antipsychotic drugs may be highly prone to metabolic disorders such as weight gain, dyslipidemia, and insulin resistance. The objective of the present study was to compare the effect of atypical and conventional antipsychotics on lipid profile. 128 schizophrenic patients were enrolled into the study. Patients were divided into two groups. One group had received one type of atypical antipsychotic drug, and, the other, one type of conventional antipsychotic drug. They were considered as atypical and conventional groups. Moreover, both groups had not used any other antipsychotic drugs during the past year. Demographic data and food frequency questionnaire were completed by the participants. Serum triglyceride, total cholesterol (TC), high-density lipoprotein and low-density lipoprotein (LDL) cholesterols, and apolipoprotein A and B (Apo B) were tested by blood sample drawing after 12 hours of fasting through the antecubital vein. Student's t-test was used to compare atypical and conventional groups. There was no significant difference in age, gender, duration of illness, period of drug consumption, and age at onset of illness in the two groups. Patients in the atypical group used clozapine and risperidone (46.9%) more than olanzapine. In the conventional group 81.3% of patients used phenothiazines. Comparison between lipid profile in the conventional and atypical groups showed a significantly higher mean in TC (P = 0.01), LDL (P = 0.03), and Apo B (P = 0.01) in conventional group than the atypical group. In schizophrenic patients, the level of lipid profile had been increased in both atypical and conventional antipsychotic users, especially conventional users, so the effect of antipsychotic drugs should be investigated periodically.
    ARYA Atherosclerosis 05/2013; 9(3):198-202.
Show more